Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 1.00 |
| ▸ | HPGD | P15428 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | NPC1 | O15118 | 2/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 2/20 | 1.00 |
| ▸ | RAB9A | P51151 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | TP53 | P04637 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 1.00 |
| ▸ | S100A4 | P26447 | 1/20 | 1.00 |
| ▸ | MTOR | P42345 | 1/20 | 1.00 |
| ▸ | NFKB2 | Q00653 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL161628 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTTDP1HPGDKMT2A | |
| SCHEMBL20774334 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTTDP1HPGDKMT2A | |
| SCHEMBL11837169 | 0.86 | MAPT (0.74) | ALDH1A1MAPTTDP1HPGDKMT2A | |
| SCHEMBL11837176 | 0.86 | MAPT (0.74) | ALDH1A1MAPTTDP1HPGDKMT2A | |
| SCHEMBL11841569 | 0.82 | ALDH1A1 (0.67) | ALDH1A1MAPTTDP1HPGDKMT2A | |
| SCHEMBL2578234 | 0.81 | TLR9 (1.00) | ALDH1A1MAPTTDP1HPGDKMT2A | |
| SCHEMBL2578236 | 0.81 | TLR9 (1.00) | ALDH1A1MAPTTDP1HPGDKMT2A | |
| SCHEMBL14141134 | 0.81 | ALDH1A1 (0.68) | ALDH1A1MAPTTDP1HPGDKMT2A | |
| SCHEMBL20774379 | 0.81 | ALDH1A1 (0.68) | ALDH1A1MAPTTDP1HPGDKMT2A | |
| SCHEMBL20774381 | 0.81 | ALDH1A1 (0.68) | ALDH1A1MAPTTDP1HPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1942 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026087695-A1 | TREATMENT FOR METABOLIC DISORDER | SAPREME TECHNOLOGIES B.V. (NL) | 2026-04-30 | — | — | WO | claimed |
| WO-2026087680-A1 | TREATMENT FOR CARDIOVASCULAR DISEASE | SAPREME TECHNOLOGIES B.V. (NL) | 2026-04-30 | — | — | WO | claimed |
| US-20260091162-A1 | SPRAYABLE POLYMERIC SCAFFOLD LOADED WITH INFLAMMASOME-INHIBITING LIPID NANORODS FOR ANTI-INFLAMMATION THERAPY | KULKARNI ASHISH (US) | 2026-04-02 | — | — | US | claimed |
| US-20260035753-A1 | METHODS OF DETERMINING BACTERIA AND MANUFACTURING A FIBROUS WEB AND TOOLS AND USES RELATED THERETO | KEMIRA OYJ (FI) | 2026-02-05 | — | — | US | claimed |
| EP-4662200-A1 | METHOD FOR PREPARING ARYLVINYLSULPHONES | Kemira OYJ (FI) | 2025-12-17 | — | — | EP | claimed |
| US-20250375534-A1 | COMPLEXES FOR DELIVERY OF NUCLEIC ACIDS | BioNTech SE (DE) | 2025-12-11 | — | — | US | claimed |
| US-20250364144-A1 | CANCER PHARMACOPREVENTION THROUGH ARTIFICIAL INTELLIGENCE | UNIV ILLINOIS (US) | 2025-11-27 | — | — | US | claimed |
| EP-3528776-B1 | REDUCED-ETHANOL MOUTH RINSE FORMULATIONS | KENVUE BRANDS LLC (US) | 2025-11-26 | — | — | EP | claimed |
| US-20250262241-A1 | METHODS TO IMPROVE STABILITY OF VIRUS TRANSDUCTION OF y8 T CELLS AND APPLICATIONS THEREOF | UNICET BIOTECH CO LLC (CN) | 2025-08-21 | — | — | US | claimed |
| US-20250235456-A1 | METHODS OF USE FOR AZA-QUINAZOLINE COMPOUNDS | IAMBIC THERAPEUTICS, INC. | 2025-07-24 | — | — | US | claimed |
| EP-2316413-A2 | Compositions comprising an nfkb-inhibitor and a non-retinoid collagen promoter | Johnson and Johnson Consumer Companies, Inc. (US) | 2011-05-04 | — | — | EP | claimed |
| US-20110081431-A1 | COMPOSITIONS COMPRISING AN NFkB-INHIBITOR AND A NON-RETINOID COLLAGEN PROMOTER | KENVUE BRANDS LLC | 2011-04-07 | — | — | US | claimed |
| US-20110081430-A1 | COMPOSITIONS COMPRISING AN NFkB-INHIBITOR AND A TROPOELASTIN PROMOTER | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. | 2011-04-07 | — | — | US | claimed |
| US-20110081433-A1 | COMPOSITIONS COMPRISING AN ANTI-INFLAMMATORY BLEND | JOHNSON & JOHNSON CONSUMER INC. | 2011-04-07 | — | — | US | claimed |
| US-20090082371-A1 | Treatment of Viral Disease and Cancer With Nf-kappaB Inhibitors | LU ZHIMIN | 2009-03-26 | — | — | US | claimed |
| WO-2006109196-A2 | TRANSGENIC MOUSE MODELS OF HEPATITIS C VIRUS (HCV) AND IDENTIFICATION OF HCV THERAPEUTICS | TRIPEP AB (SE) | 2006-10-19 | — | — | WO | claimed |
| US-20060194769-A1 | Small molecules that reduce fungal growth | UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2006-08-31 | — | — | US | claimed |
| WO-2006081327-A2 | SMALL MOLECULES THAT REDUCE FUNGAL GROWTH | UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2006-08-03 | — | — | WO | claimed |
| US-20040241166-A1 | Screening by contacting inhibitor (sulindac) with endothelial cells activated by blood platelets, and determining secretion of MCP-1 (Monocyte chemoattractant protein-1); for treatment and prevention of atherosclerosis | PROCORDE GMBH (DE) | 2004-12-02 | — | — | US | claimed |
| EP-1372689-B1 | USE OF IKK-BETA INHIBITORS AND METHOD FOR DISCOVERY OF SAID INHIBITORS | PROCORDE GMBH (DE) | 2004-07-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060194769-A1 | Small molecules that reduce fungal growth | ERG28, DPM1, CYP51A1 | ALDH1A1 2931/4885MAPT 1481/4885TDP1 3838/4885 |
| US-20110081431-A1 | COMPOSITIONS COMPRISING AN NFkB-INHIBITOR AND A NON-RETINOID COLLAGEN PROMOTER | NFKBIA, NFRKB, NFKB1 | ALDH1A1 2842/4885MAPT 2768/4885TDP1 1199/4885 |
| US-20250262241-A1 | METHODS TO IMPROVE STABILITY OF VIRUS TRANSDUCTION OF y8 T CELLS AND APPLICATIONS THEREOF | CD4, NFATC1, ICOS | ALDH1A1 4618/4885MAPT 1318/4885TDP1 2134/4885 |
| US-20250375534-A1 | COMPLEXES FOR DELIVERY OF NUCLEIC ACIDS | TLR3, TLR9, SARNP | ALDH1A1 4446/4885MAPT 3674/4885TDP1 1427/4885 |
| US-20090082371-A1 | Treatment of Viral Disease and Cancer With Nf-kappaB Inhibitors | RELA, NFKBIA, NFKB1 | ALDH1A1 1659/4885MAPT 3202/4885TDP1 1101/4885 |
| US-20250235456-A1 | METHODS OF USE FOR AZA-QUINAZOLINE COMPOUNDS | AZI2, TPMT, HDAC10 | ALDH1A1 713/4885MAPT 4100/4885TDP1 506/4885 |
| US-20260035753-A1 | METHODS OF DETERMINING BACTERIA AND MANUFACTURING A FIBROUS WEB AND TOOLS AND USES RELATED THERETO | POLL, UROD, RNGTT | ALDH1A1 2058/4885MAPT 228/4885TDP1 162/4885 |
| US-20110081430-A1 | COMPOSITIONS COMPRISING AN NFkB-INHIBITOR AND A TROPOELASTIN PROMOTER | NFKBIA, NFKB1, NFKB2 | ALDH1A1 2391/4885MAPT 702/4885TDP1 71/4885 |
| US-20260091162-A1 | SPRAYABLE POLYMERIC SCAFFOLD LOADED WITH INFLAMMASOME-INHIBITING LIPID NANORODS FOR ANTI-INFLAMMATION THERAPY | NLRP3, NLRP1, IL1B | ALDH1A1 1965/4885MAPT 484/4885TDP1 2703/4885 |
| US-20110081433-A1 | COMPOSITIONS COMPRISING AN ANTI-INFLAMMATORY BLEND | NFKBIA, NFKB2, NFKB1 | ALDH1A1 4161/4885MAPT 374/4885TDP1 2135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.